GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for BioPharmX Corporation Stock and on which exchange is it traded?
The symbol for BioPharmX Corporation is BPMX and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell BioPharmX Corporation Stock?
BioPharmX Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy BioPharmX Corporation Stock?
BioPharmX Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioPharmX Corporation Stock.

What's the current price of BioPharmX Corporation Stock?
As of the end of day on the 2022-08-17, the price of an BioPharmX Corporation (BPMX) share was $0.279.

What is the 52-week high and low for BioPharmX Corporation Stock?
The 52-week high for BioPharmX Corporation Stock is $1.12 and the 52-week low is $0.241.
Click to get the best stock tips daily for free!

About BioPharmX Corporation

BioPharmX BioPharmX Corporation, a specialty pharmaceutical company, focuses on the development of novel drug delivery products for women's health and dermatology markets. The company offers prescription and over-the-counter (OTC) products in oral, topical, and injectable forms. It provides VI2OLET iodine, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort and for the alleviation of symptoms of fibrocystic breast condition (... BPMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT